Smart money activity in the past 24 hours that is out of the ordinary. It includes stock options bought on the ask or sold on the bid with unusual size and daily volume compared to open interest.

Find out more


Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharmaceuticals segments. The Diabetes and Obesity Care segment covers insulins, glucagon-like-peptide 1, other protein-related products, oral anti-diabetic drugs and obesity. The Biopharmaceuticals segment involves in the research, development, manufacture, and distribution of products within the areas of haemophilia, growth hormone, hormone replacement, inflammation, and therapy areas. The company was founded by August Krogh, Marie Krogh, Hans Christian Hagedorn, August Kongsted, Harald Pedersen, and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

UOA Trade History
Loading...


No unusual activity trades found. Try filtering by a different expiration or applying global filters to show complex (spreads, buy-write etc) & sold on the bid trades.